SMAD7 and lung carcinoma: Interestingly, it can also act as an anti-tumor immunotherapeutic agent thanks to its inductive effect on Smad7 in combination with naringenin (Smad3 inhibitor), which increases the ability of NK cells to inhibit the progression of invasive melanoma and lung carcinoma in animal models and in vivo.